WITHDRAWAL OF INFLIXIMAB OR ANTI-METABOLITE THERAPY IN CROHN'S DISEASE PATIENTS IN SUSTAINED REMISSION ON COMBINATION THERAPY: A RANDOMIZED UNBLINDED CONTROLLED TRIAL (SPARE)

Louis E., Resche-Rigon M., Laharie D., Satsangi JJ., Ding NS., Siegmund B., D'Haens GR., Picon L., Bossuyt P., Vuitton L., Irving PM., Bouhnik Y., Viennot S., Lamb CA., Pollock RC., Baert FJ., Nachury M., Fumery M., Gilletta C., Colombel JF., Hertervig E.

Type

Conference paper

Publication Date

05/2022

Volume

162

Pages

S216 - S216

Permalink